venukb.com – When short interest in a company’s stocks more than doubles in a single month, investors should pay attention. Kamada Ltd. (NASDAQ: KMDA), a biopharmaceutical producer best known for its plasma-derived therapies, just experienced a 112.9% surge in short interest, reaching 166,435 shares. That figure represents roughly 0.5% of its outstanding stocks, a relatively